cept Therapeutics rporated-Does Corcept (CORT) Have the Potential to Rally 28.63% as Wall Street Analysts Expect?

Corcept Therapeutics (CORT) closed the last trading session at $91.93, gaining 64.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 118.25 indicates a 28.6% upside potential.The average comprises four short-term price targets ranging from a low of $78 to a high of$ 150, with a standard deviation of $30.42. While the lowest estimate indicates a decline of 15.2% from the current pr ...